Companies›Healthcare›Healthcare›Healthcare Services
NSE:TAKE

TAKE LIMITED

Healthcare › Healthcare Services
₹10.93
at close · 23 Oct 2026
▼ 0.38 (-3.36%)

Latest filings

  1. Routine RTA compliance certificate for Q2 FY27 demat · Compliance
  2. TAKE Limited 25th AGM: all 5 resolutions passed with over 99.98% approval · Compliance
  3. TAKE Limited 25th AGM - 5 Resolutions Tabled, Healthcare AI Vision Shared · Board & Shareholder Meetings
All filings ↓
Ask Nexa about TAKE LIMITED

Snapshot

What the business is, and whether it's a good one at a fair price.

A Healthcare Services company listed on NSE and BSE, reporting revenue of ₹85 Cr over the trailing twelve months.

Market Cap
₹162 Cr
P / E (TTM)
12.7×
EV / EBITDA
25.9×
Div Yield
—
Growth
-41.2%▼
Revenue 5y CAGR
PAT — · EBITDA —
Quality
15.4%▲
ROCE (FY26)
ROE 35.0% · margin 8.8%
Leverage
0.00·
Debt / Equity · low
Net cash ₹0.26 Cr
Revenue FY20→FY26
0.0×▼
Margin +20.5 pts
₹2,213 Cr → ₹54 Cr
Moves on a normal day
2.61%·
Median daily move
Last 268 sessions · the yardstick for filing-day moves
Where it sits among 70 Healthcare Services peersBar = share of peers beaten · tick = industry median · latest reported figures
P/E (TTM)#12/63
P/B#33/57
ROCE#15/69
ROE#2/57
Debt / Equity#1/56
EBITDA margin#51/57
Profit growth#5/55

Scorecard

Measured from the filed financials, judged against its Healthcare Services peers · as of FY26 — not investment advice

Strengths
Returns on capital 15.4%
#15 of 69 in Healthcare Services on the latest reported figures · up from 1.6% in FY20
No borrowings on the balance sheet
lower than 80% of its 56 Healthcare Services peers
Negative working-capital cycle — the business is funded by its suppliers
Concerns
Revenue shrinking over 5 years (−41% a year)

Charts

How has the market priced it — with filings on the timeline?

TAKE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Peers

How does it stack up on valuation, returns and growth?

Loading peers…

Financials

Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.

Loading financials…

Ownership

Who owns it — and is the promoter stake clean?

Loading shareholding…

Sign up to see the full company file

Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.

Common questions

Answered from TAKE LIMITED's filed financials and exchange disclosures

What does TAKE LIMITED do?

TAKE LIMITED is a Healthcare Services company listed on NSE and BSE, trading under the symbol TAKE.

Is TAKE LIMITED profitable?

Yes. Over the trailing twelve months TAKE LIMITED reported a net profit of ₹13 Cr on revenue of ₹85 Cr.

Does TAKE LIMITED pay a dividend?

Not in the latest reported year — TAKE LIMITED's dividend payout for FY26 was nil.

Is TAKE LIMITED debt-free?

Yes. It reported no borrowings on its 31 Mar 2026 balance sheet, and ₹0.26 Cr of cash.

Is TAKE LIMITED expensive compared with its peers?

On trailing P/E, TAKE LIMITED ranks 12 of 63 in Healthcare Services — cheaper than 82% of them, against an industry median of 34.0×. This is a position, not a valuation judgement.

How much does the TAKE LIMITED share price move in a day?

On a typical session TAKE LIMITED moves 2.61% — that is the median absolute close-to-close move across its last 268 trading days. MarketPing measures each filing's price reaction against it.

Where can I track TAKE LIMITED's announcements?

Every NSE and BSE filing by TAKE LIMITED appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.

Figures are as last reported and may lag the latest filing. Not investment advice.